neoplasm
• following adenoviral cre treatment, liver tumor development is increased compared to in untreated mice (on average 18% from 3%)
|
• following treatment with adenoviral cre, 15% of mice exhibit osseous metaplasia compared to 2% of wild-type mice
|
• following treatment with adenoviral cre, meningioma development is increased compared to in untreated mice (on average 37% from 13%)
• meningiomas in adenoviral cre-treated mice share radiological features with human meningiomas
|
• following treatment with adenoviral cre, osteoma development is increased compared to in untreated mice (on average 78% from 57%)
|
nervous system
• following treatment with adenoviral cre, meningioma development is increased compared to in untreated mice (on average 37% from 13%)
• meningiomas in adenoviral cre-treated mice share radiological features with human meningiomas
|
hydrocephaly
(
J:131179
)
• following adenoviral cre treatment, hydrocephalus is increased compared to in untreated mice (on average 56% from 36%)
|
• following adenoviral cre treatment, meningothelial proliferation is increased compared to in untreated mice (on average 77% from 46%)
|
skeleton
• following treatment with adenoviral cre, osteoma development is increased compared to in untreated mice (on average 78% from 57%)
|
liver/biliary system
• following adenoviral cre treatment, liver tumor development is increased compared to in untreated mice (on average 18% from 3%)
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
familial meningioma | DOID:4586 | J:131179 |